Glucocorticoids and mepolizumab in eosinophilic asthma

New England Journal of Medicine

Volumn 371, Issue 25, 2014, Pages 2433-2434

  Lindsay, John T ^a   Heaney, Liam ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; HYDROCORTISONE; MEPOLIZUMAB; PLACEBO; PREDNISONE;

ADRENAL INSUFFICIENCY; ASTHMA; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG COST; DRUG DOSE REDUCTION; EOSINOPHILIA; EOSINOPHILIC ASTHMA; HUMAN; HYDROCORTISONE BLOOD LEVEL; LETTER; MAINTENANCE THERAPY; PATIENT COMPLIANCE;

EID: 84919372003     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1412892     Document Type: Letter

References (2)

1. Bel EH, Wenzel SE, Thompson PJ, et al. Oral glucocorticoidsparing effect of mepolizumab in eosinophilic asthma. N Engl J Med 2014;371:1189-97.
2. Gamble J, Stevenson M, McClean E, Heaney LG. The prevalence of nonadherence in difficult asthma. Am J Respir Crit Care Med 2009;180:817-22.